FORA Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

FORA Capital’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,148	Closed	-$1.31M	–	605
2023 Q4	$1.31M	Buy	+4,148	New	+$806K	0.11%	219
2022 Q4	–	Sell	-4,452	Closed	-$1M	–	662
2022 Q3	$1M	Buy	+4,452	New	+$901K	0.19%	157
2021 Q2	–	Sell	-554	Closed	-$67K	–	1206
2021 Q1	$67K	Buy	+554	New	+$62.8K	0.02%	495
2020 Q3	–	Sell	-3,014	Closed	-$336K	–	1061
2020 Q2	$336K	Buy	+3,014	New	+$262K	0.12%	230

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

FORA Capital's KRTX Position: Q1 2024 in Review

FORA Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,148 shares — an estimated $1.31M sold.

FORA Capital first reported a position in KRTX in Q2 2020 and held it in 4 quarters. The position peaked at $1.31M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

FORA Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
FORA Capital sold 4,148 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.31M.
FORA Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
FORA Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $1.31M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on FORA Capital's 13F filing for Q1 2024, filed 2 May 2024.